1. Home
  2. ASMB vs ATGL Comparison

ASMB vs ATGL Comparison

Compare ASMB & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • ATGL
  • Stock Information
  • Founded
  • ASMB 2005
  • ATGL 2017
  • Country
  • ASMB United States
  • ATGL Hong Kong
  • Employees
  • ASMB N/A
  • ATGL N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • ATGL
  • Sector
  • ASMB Health Care
  • ATGL
  • Exchange
  • ASMB Nasdaq
  • ATGL Nasdaq
  • Market Cap
  • ASMB 100.5M
  • ATGL 89.7M
  • IPO Year
  • ASMB 2010
  • ATGL 2023
  • Fundamental
  • Price
  • ASMB $14.72
  • ATGL $12.70
  • Analyst Decision
  • ASMB Buy
  • ATGL
  • Analyst Count
  • ASMB 2
  • ATGL 0
  • Target Price
  • ASMB $35.00
  • ATGL N/A
  • AVG Volume (30 Days)
  • ASMB 23.4K
  • ATGL 203.1K
  • Earning Date
  • ASMB 11-07-2024
  • ATGL 12-03-2024
  • Dividend Yield
  • ASMB N/A
  • ATGL N/A
  • EPS Growth
  • ASMB N/A
  • ATGL N/A
  • EPS
  • ASMB N/A
  • ATGL N/A
  • Revenue
  • ASMB $28,326,000.00
  • ATGL $1,171,763.00
  • Revenue This Year
  • ASMB $267.67
  • ATGL N/A
  • Revenue Next Year
  • ASMB $46.15
  • ATGL N/A
  • P/E Ratio
  • ASMB N/A
  • ATGL N/A
  • Revenue Growth
  • ASMB N/A
  • ATGL 21.27
  • 52 Week Low
  • ASMB $8.16
  • ATGL $1.15
  • 52 Week High
  • ASMB $19.93
  • ATGL $19.80
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 35.66
  • ATGL 65.84
  • Support Level
  • ASMB $15.92
  • ATGL $11.18
  • Resistance Level
  • ASMB $17.48
  • ATGL $14.30
  • Average True Range (ATR)
  • ASMB 1.07
  • ATGL 1.80
  • MACD
  • ASMB -0.25
  • ATGL 0.17
  • Stochastic Oscillator
  • ASMB 28.54
  • ATGL 76.19

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

Share on Social Networks: